The Join Corp. (NASDAQ: JYNT)
The Join Corp. Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
The Join Corp. Company Info
The Joint Corp. engages in the development, ownership, operation, support, and management of chiropractic clinics. It operates through two segments: Corporate Clinics and Franchise Operations. The Corporate Clinics segment consists of the operating activities of the company-owned or managed clinics. The Franchise Operations segment includes the operating activities of the franchise business unit. The Joint was founded by Fred Gerretzen, Charles Barnwell, John Leonesio, Todd Welker, Barbara Holland, Steven P. Colmar, Craig P. Colmar, and Richard Rees on March 10, 2010 and is headquartered in Scottsdale, AZ.
News & Analysis
Got $1,000? Buy This Hot Growth Stock Before It Takes Off
Shares of small-cap healthcare company The Joint Corp. have been crushed. Did this create a nice buying opportunity?
This Beaten-Down Growth Stock Could Double Your Money in 5 Years
Adopting a long-term mindset, while focusing on the fundamentals, will benefit investors in this situation.
This Under-the-Radar Stock Outpaced Bitcoin in 2021 -- Is It a Smart Buy Right Now?
Riding the wellness craze has been an absolute boon for this business and its shareholders.
This Fast-Growing Healthcare Stock Will Win Even if the Economy Goes Bad
The Joint is an exciting growth stock. But it's also a great defensive stock if the economy heads south.
This Chiropractic Company Is Shooting The Lights Out
This company has been greatly improving both spines and shareholder returns.
Even Cathie Wood Can't Outperform This Unstoppable Growth Stock
Providing an improved customer experience is propelling this health and wellness business to new heights.
3 Stocks to Buy if They Take a Dip
Finding bargains in the market is a rarity these days, so you should load up on shares of these businesses if the opportunity presents itself.
2 Stocks I Bought Last Week
One is a small-cap that's using the franchise model with chiropractors, and one is a tiny biotech that just might be the biggest stock of 2022.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.